FDA Recalls Common Heart Medication Over Possible Cancer Risk

Photo by tommyandone from Envato Elements

Who Makes This Drug?

The recalled tablets were manufactured by Unichem Laboratoris Ltd., based in Goa, India, and distributed in the U.S. by Unichem Pharmaceuticals (USA), Inc. of East Brunswick, New Jersey. The company describes itself as one of the leading players in the global generic pharmaceutical industry.

The FDA’s recall was triggered by what it terms “cGMP Deviations”—meaning the manufacturer did not comply with the agency’s Current Good Manufacturing Practice regulations, which govern how pharmaceuticals must be produced to ensure quality and safety. Under U.S. law, any drug manufactured in violation of these standards is considered “adulterated,” regardless of whether it causes direct harm.

« 1 ... 6 7 8»
Facebook
Twitter
Telegram
Reddit

10 Responses

  1. What are the names of the medications. You’re not helping anyone when you don’t even listen the names of the medications

    1. The recall affects Bisoprolol Fumarate (2.5 mg) and Hydrochlorothiazide (6.25 mg) tablets — a combination medication commonly prescribed to treat high blood pressure. The affected product comes in 100-count bottles and was distributed throughout the United States and Puerto Rico.

    1. The recall affects Bisoprolol Fumarate (2.5 mg) and Hydrochlorothiazide (6.25 mg) tablets — a combination medication commonly prescribed to treat high blood pressure. The affected product comes in 100-count bottles and was distributed throughout the United States and Puerto Rico.

  2. The recall affects Bisoprolol Fumarate (2.5 mg) and Hydrochlorothiazide (6.25 mg) tablets — a combination medication commonly prescribed to treat high blood pressure. The affected product comes in 100-count bottles and was distributed throughout the United States and Puerto Rico.

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Posts